Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
International Surgery
|
October 1, 1986
Thrombosis prevention with ticlopidine after femoropopliteal thromboendarterectomy
P Castelli, A Basellini, G B Agus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules
F Arienti, C Gambacorti-Passerini, L Borin, et al.
Haematologica
|
October 12, 2000
Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura
F Radaelli, P Faccini, M Goldaniga, et al.
Transfusion
|
September 1, 2005
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds
Paolo Perseghin, Gianalfredo Sciorelli, Daniela Belotti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 22, 2010
Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000-2002
Lorenzo Cirasino, Anna M Robino, Marco Cattaneo, et al.
British Journal of Haematology
|
June 15, 2005
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study
Agostino Cortelezzi, Marco Moia, Anna Falanga, et al.
Clinical Drug Investigation
|
March 29, 2008
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes
F Rossini, P Pioltelli, S Bolis, et al.
Tumori
|
July 1, 1995
Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up
E M Pogliani, F Rossini, I Miccolis, et al.
Blood Cells, Molecules & Diseases
|
August 16, 2006
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years
Rocco G Piazza, Vera Magistroni, Anna Franceschino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1994
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors
F Rossini, P Pioltelli, S Mingozzi, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
International Surgery
|
October 1, 1986
Thrombosis prevention with ticlopidine after femoropopliteal thromboendarterectomy
P Castelli, A Basellini, G B Agus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules
F Arienti, C Gambacorti-Passerini, L Borin, et al.
Haematologica
|
October 12, 2000
Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura
F Radaelli, P Faccini, M Goldaniga, et al.
Transfusion
|
September 1, 2005
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds
Paolo Perseghin, Gianalfredo Sciorelli, Daniela Belotti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 22, 2010
Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000-2002
Lorenzo Cirasino, Anna M Robino, Marco Cattaneo, et al.
British Journal of Haematology
|
June 15, 2005
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study
Agostino Cortelezzi, Marco Moia, Anna Falanga, et al.
Clinical Drug Investigation
|
March 29, 2008
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes
F Rossini, P Pioltelli, S Bolis, et al.
Tumori
|
July 1, 1995
Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up
E M Pogliani, F Rossini, I Miccolis, et al.
Blood Cells, Molecules & Diseases
|
August 16, 2006
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years
Rocco G Piazza, Vera Magistroni, Anna Franceschino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1994
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors
F Rossini, P Pioltelli, S Mingozzi, et al.
Page
of 14